BD Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results : vimarsana.com

Execution of BD 2025 Strategy Driving Durable, Broad-Based Growth Q4 revenue of $5.1 billion increased 6.8% as reported and 5.9% on a currency-neutral basis Q4...

Related Keywords

China , Russia , Ukraine , United States , America , Troy Kirkpatrick , Transjugular Intrahepatic Portosystemic , Tom Polen , Embecta Corp , Revenue Growth , Bd Life Sciences Revenues , Bd Life Sciences , Life Sciences , Solutions Revenues , Linkedin , Diagnostics Solutions , Medication Management Solutions , Research Instruments , Medication Delivery Solutions , European Union Medical Device Regulation , Casella Waste Systems Inc , Bd Respiratory Viral Panel , Catheter Solutions , Exchange Commission , Driving Durable , Infusion System , Stick Hospital , Pro Needle Free Blood Collection Device , Integrated Diagnostics Solutions , Viral Panel , Peripheral Intervention , Transjugular Intrahepatic Portosystemic Shunt , Stent Graft , Best Code , Corporate Citizens , Casella Waste Systems , Quarter Fiscal , Diluted Earnings , Organic Revenue Growth , Base Revenues , Months Ended September , Organic Revenues , Pharmaceutical Systems , North America , Vascular Access Management , Pharmacy Automation , Integrated Diagnostic Solutions , Total Modular Track , Specimen Management , Clinical Reagents , Critical Care , Advanced Repair , Infection Prevention , Surgical Instrumentation , Peripheral Vascular Disease , Atherectomy System , Targeted Temperature Management , Digital Endoscope , Full Year Fiscal , Diabetes Care , Devices Regulations , Middle East , Adam Reiffe , Investor Relations , Public Relations , Discontinued Operations , Diagnostic Testing , Organic Revenue , Continuing Operations , Foreign Currency , Bd Becton , Ickinson And Company ,